CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $2,743,765
- in 2 filings
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net +$1,035,724. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$2.7M President and CEO 2 filings
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +35,000 | 35,000 | ||
| 2025-12-09 | Hasnain Faheem Director | Option exercise | +10,000 | $3.12 | $31K | 33,983 |
| 2025-12-09 | Hasnain Faheem Director | Sale | −10,000 | $10.98 | $110K | 23,983 |
| 2025-06-05 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +28,500 | 28,500 | ||
| 2025-03-21 | Hasnain Faheem Director | Option exercise | +22,682 | $6.32 | $143K | 46,665 |
| 2025-03-21 | Hasnain Faheem Director | Sale | −22,682 | $8.00 | $181K | 23,983 |
| 2024-06-05 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 |
Page 1 of 1 · 7 trades